| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.907 | 0.001 | 0.96 | Adrenaline uptake inhibitor | 0.891 0.002 DBMET02409 0.86 0.002 DBMET02410 0.614 0.003 DBMET02411 0.96 0.001 DBMET02412 0.88 0.002 DBMET00437 0.589 0.003 DBMET00958 | DBMET02412 | |
| 0.864 | 0.004 | 0.864 | Antiadrenergic | 0.859 0.004 DBMET02409 0.767 0.004 DBMET02410 0.27 0.016 DBMET02411 0.481 0.006 DBMET02412 0.696 0.004 DBMET00437 0.152 0.035 DBMET00958 | ||
| 0.862 | 0.004 | 0.862 | Adrenaline antagonist | 0.856 0.004 DBMET02409 0.764 0.004 DBMET02410 0.266 0.016 DBMET02411 0.477 0.006 DBMET02412 0.69 0.004 DBMET00437 0.147 0.035 DBMET00958 | ||
| 0.852 | 0.003 | 0.912 | 5 Hydroxytryptamine uptake inhibitor | 0.829 0.003 DBMET02409 0.783 0.003 DBMET02410 0.47 0.004 DBMET02411 0.912 0.002 DBMET02412 0.797 0.003 DBMET00437 0.414 0.005 DBMET00958 | DBMET02412 | |
| 0.825 | 0.005 | 0.922 | Analgesic | 0.797 0.006 DBMET02409 0.794 0.006 DBMET02410 0.536 0.04 DBMET02411 0.922 0.004 DBMET02412 0.805 0.005 DBMET00437 0.519 0.044 DBMET00958 | DBMET02412 | |
| 0.717 | 0.005 | 0.814 | Spasmolytic | 0.745 0.005 DBMET02409 0.724 0.005 DBMET02410 0.814 0.004 DBMET02411 0.348 0.053 DBMET02412 0.58 0.015 DBMET00437 0.682 0.007 DBMET00958 | DBMET02411 | |
| 0.694 | 0.009 | 0.702 | Aldehyde oxidase inhibitor | 0.702 0.008 DBMET02409 0.687 0.009 DBMET02410 0.323 0.061 DBMET02412 0.485 0.035 DBMET00437 | DBMET02409 | |
| 0.587 | 0.005 | 0.587 | Sigma receptor agonist | 0.563 0.005 DBMET02409 0.552 0.005 DBMET02410 0.27 0.045 DBMET02411 0.525 0.008 DBMET02412 0.546 0.006 DBMET00437 0.196 0.063 DBMET00958 | ||
| 0.494 | 0.004 | 0.494 | ABCA1 expression enhancer | 0.484 0.004 DBMET02409 0.485 0.004 DBMET02410 0.222 0.008 DBMET02411 | ||
| 0.497 | 0.009 | 0.518 | P-glycoprotein inhibitor | 0.518 0.007 DBMET02409 0.492 0.009 DBMET02410 0.376 0.019 DBMET02411 0.233 0.047 DBMET02412 0.476 0.01 DBMET00437 0.359 0.02 DBMET00958 | DBMET02409 | |
| 0.476 | 0.039 | 0.564 | Immunosuppressant | 0.471 0.041 DBMET02409 0.533 0.025 DBMET02410 0.564 0.018 DBMET02411 0.224 0.172 DBMET02412 0.391 0.067 DBMET00437 0.532 0.025 DBMET00958 | DBMET02411 | |
| 0.431 | 0.005 | 0.457 | Anesthetic local | 0.457 0.005 DBMET02409 0.429 0.005 DBMET02410 0.127 0.062 DBMET02412 0.279 0.015 DBMET00437 | DBMET02409 | |
| 0.437 | 0.012 | 0.539 | Anesthetic general | 0.421 0.014 DBMET02409 0.539 0.006 DBMET02410 0.416 0.014 DBMET02411 0.23 0.059 DBMET02412 0.348 0.024 DBMET00437 0.324 0.028 DBMET00958 | DBMET02410 | |
| 0.389 | 0.003 | 0.389 | Liver X receptor agonist | 0.377 0.003 DBMET02409 0.351 0.003 DBMET02410 0.14 0.005 DBMET02411 | ||
| 0.343 | 0.005 | 0.43 | NMDA receptor antagonist | 0.239 0.01 DBMET02409 0.223 0.011 DBMET02410 0.107 0.043 DBMET02412 0.43 0.004 DBMET00437 | DBMET00437 | |
| 0.343 | 0.014 | 0.368 | Lipocortins synthesis antagonist | 0.332 0.016 DBMET02409 0.368 0.011 DBMET02410 0.281 0.025 DBMET02411 0.31 0.019 DBMET02412 0.324 0.017 DBMET00437 0.269 0.028 DBMET00958 | DBMET02410 | |
| 0.379 | 0.054 | 0.654 | Cholesterol antagonist | 0.389 0.052 DBMET02409 0.553 0.025 DBMET02410 0.654 0.012 DBMET02411 0.286 0.1 DBMET02412 0.328 0.075 DBMET00437 0.614 0.017 DBMET00958 | DBMET02411 | |
| 0.351 | 0.049 | 0.439 | Calcium channel activator | 0.335 0.06 DBMET02409 0.389 0.029 DBMET02410 0.321 0.072 DBMET02412 0.439 0.013 DBMET00437 0.24 0.159 DBMET00958 | DBMET00437 | |
| 0.354 | 0.053 | 0.549 | Vasodilator, coronary | 0.384 0.041 DBMET02409 0.386 0.04 DBMET02410 0.549 0.01 DBMET02411 0.215 0.168 DBMET02412 0.329 0.067 DBMET00437 0.518 0.013 DBMET00958 | DBMET02411 | |
| 0.403 | 0.109 | 0.459 | Caspase 9 stimulant | 0.427 0.095 DBMET02409 0.459 0.078 DBMET02410 0.379 0.124 DBMET02411 0.272 0.226 DBMET02412 0.37 0.13 DBMET00437 0.347 0.148 DBMET00958 | DBMET02410 | |
| 0.362 | 0.069 | 0.409 | Vasodilator, peripheral | 0.409 0.052 DBMET02409 0.391 0.058 DBMET02410 0.339 0.078 DBMET02411 0.267 0.115 DBMET00437 0.247 0.129 DBMET00958 | DBMET02409 | |
| 0.296 | 0.004 | 0.304 | Dopamine uptake inhibitor | 0.254 0.005 DBMET02409 0.304 0.004 DBMET02410 0.058 0.04 DBMET02412 0.252 0.005 DBMET00437 | DBMET02410 | |
| 0.296 | 0.015 | 0.296 | Cholinergic antagonist | 0.271 0.018 DBMET02409 0.276 0.017 DBMET02410 0.105 0.088 DBMET02412 0.252 0.02 DBMET00437 | ||
| 0.329 | 0.055 | 0.394 | Sodium/bile acid cotransporter inhibitor | 0.317 0.064 DBMET02409 0.394 0.019 DBMET02410 0.265 0.113 DBMET02411 0.289 0.089 DBMET02412 0.337 0.048 DBMET00437 0.278 0.1 DBMET00958 | DBMET02410 | |
| 0.302 | 0.032 | 0.311 | Tyrosine 3 hydroxylase inhibitor | 0.309 0.029 DBMET02409 0.23 0.09 DBMET02410 0.274 0.048 DBMET02412 0.311 0.028 DBMET00437 | DBMET00437 | |
| 0.275 | 0.01 | 0.275 | Nav1.1 sodium channel blocker | 0.236 0.013 DBMET02409 0.222 0.015 DBMET02410 0.13 0.042 DBMET02412 0.246 0.012 DBMET00437 | ||
| 0.297 | 0.032 | 0.297 | 5 Hydroxytryptamine 1E antagonist | 0.285 0.041 DBMET02409 0.222 0.106 DBMET02410 0.184 0.149 DBMET02412 0.289 0.037 DBMET00437 | ||
| 0.278 | 0.016 | 0.278 | Acetylcholine antagonist | 0.255 0.019 DBMET02409 0.26 0.019 DBMET02410 0.098 0.095 DBMET02412 0.239 0.022 DBMET00437 | ||
| 0.278 | 0.017 | 0.293 | Alpha adrenoreceptor antagonist | 0.293 0.016 DBMET02409 0.173 0.032 DBMET02410 0.197 0.028 DBMET00437 | DBMET02409 | |
| 0.282 | 0.024 | 0.323 | Neurotrophic factor enhancer | 0.302 0.017 DBMET02409 0.323 0.013 DBMET02410 0.288 0.022 DBMET02411 0.227 0.053 DBMET02412 0.305 0.017 DBMET00437 0.312 0.015 DBMET00958 | DBMET02410 | |
| 0.273 | 0.02 | 0.273 | Acetylcholine M1 receptor antagonist | 0.256 0.024 DBMET02409 0.25 0.025 DBMET02410 0.14 0.084 DBMET02412 0.23 0.031 DBMET00437 | ||
| 0.287 | 0.052 | 0.338 | 5 Hydroxytryptamine uptake stimulant | 0.338 0.029 DBMET02409 0.226 0.109 DBMET02410 0.226 0.108 DBMET02412 0.292 0.049 DBMET00437 | DBMET02409 | |
| 0.243 | 0.015 | 0.245 | Acetylcholine muscarinic antagonist | 0.223 0.019 DBMET02409 0.228 0.018 DBMET02410 0.121 0.066 DBMET02412 0.245 0.015 DBMET00437 | DBMET00437 | |
| 0.276 | 0.049 | 0.309 | Psychostimulant | 0.278 0.049 DBMET02409 0.273 0.05 DBMET02410 0.286 0.047 DBMET02411 0.299 0.043 DBMET00437 0.309 0.04 DBMET00958 | DBMET00958 | |
| 0.254 | 0.041 | 0.282 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.269 0.035 DBMET02409 0.282 0.029 DBMET02410 0.18 0.093 DBMET02411 0.161 0.124 DBMET02412 0.171 0.105 DBMET00437 | DBMET02410 | |
| 0.339 | 0.126 | 0.567 | Calcium channel L-type activator | 0.321 0.14 DBMET02412 0.567 0.01 DBMET00437 0.431 0.061 DBMET00958 | DBMET00437 | |
| 0.302 | 0.093 | 0.678 | Transcription factor NF kappa B inhibitor | 0.341 0.08 DBMET02409 0.413 0.061 DBMET02410 0.636 0.027 DBMET02411 0.35 0.077 DBMET00437 0.678 0.023 DBMET00958 | DBMET00958 | |
| 0.219 | 0.018 | 0.219 | Alpha 1 adrenoreceptor antagonist | 0.216 0.019 DBMET02409 0.12 0.037 DBMET02410 0.156 0.028 DBMET00437 | ||
| 0.202 | 0.008 | 0.202 | Prolactin inhibitor | 0.2 0.009 DBMET02409 0.166 0.016 DBMET02410 0.106 0.05 DBMET02412 0.146 0.024 DBMET00437 | ||
| 0.213 | 0.022 | 0.221 | Arachidonic acid antagonist | 0.217 0.019 DBMET02409 0.221 0.016 DBMET02410 0.154 0.083 DBMET02411 0.178 0.055 DBMET02412 0.186 0.047 DBMET00437 | DBMET02410 | |
| 0.214 | 0.027 | 0.36 | ATPase inhibitor | 0.227 0.021 DBMET02409 0.275 0.009 DBMET02410 0.354 0.004 DBMET02411 0.218 0.025 DBMET00437 0.36 0.004 DBMET00958 | DBMET00958 | |
| 0.194 | 0.011 | 0.204 | Sphingomyelinase inhibitor | 0.204 0.009 DBMET02409 0.165 0.019 DBMET02410 0.182 0.014 DBMET02411 0.093 0.068 DBMET02412 0.188 0.012 DBMET00437 0.176 0.015 DBMET00958 | DBMET02409 | |
| 0.187 | 0.005 | 0.187 | NMDA receptor subunit 3B antagonist | 0.115 0.009 DBMET02409 0.076 0.014 DBMET02410 0.056 0.021 DBMET02412 0.165 0.005 DBMET00437 | ||
| 0.188 | 0.008 | 0.218 | Acetylcholine M3 receptor antagonist | 0.153 0.011 DBMET02409 0.176 0.009 DBMET02410 0.067 0.034 DBMET02412 0.218 0.005 DBMET00437 | DBMET00437 | |
| 0.302 | 0.123 | 0.447 | Histamine release inhibitor | 0.303 0.122 DBMET02409 0.26 0.148 DBMET02410 0.447 0.051 DBMET02411 0.229 0.172 DBMET00437 0.395 0.078 DBMET00958 | DBMET02411 | |
| 0.192 | 0.014 | 0.245 | Estrogen antagonist | 0.141 0.027 DBMET02409 0.198 0.013 DBMET02410 0.245 0.009 DBMET02412 0.157 0.021 DBMET00437 | DBMET02412 | |
| 0.217 | 0.039 | 0.219 | 5 Hydroxytryptamine 3E antagonist | 0.207 0.052 DBMET02409 0.169 0.139 DBMET02410 0.219 0.037 DBMET00437 | DBMET00437 | |
| 0.175 | 0.005 | 0.184 | Dopamine transporter inhibitor | 0.166 0.005 DBMET02409 0.158 0.005 DBMET02410 0.057 0.027 DBMET02411 0.182 0.005 DBMET02412 0.184 0.005 DBMET00437 0.067 0.022 DBMET00958 | DBMET00437 | |
| 0.183 | 0.019 | 0.183 | Antineoplastic alkaloid | 0.171 0.022 DBMET02409 0.178 0.02 DBMET02410 0.08 0.065 DBMET02412 0.1 0.047 DBMET00437 | ||
| 0.185 | 0.022 | 0.207 | Adenylate cyclase stimulant | 0.198 0.014 DBMET02409 0.207 0.011 DBMET02410 0.129 0.103 DBMET02411 0.135 0.09 DBMET02412 0.201 0.013 DBMET00437 0.145 0.072 DBMET00958 | DBMET02410 | |
| 0.18 | 0.019 | 0.18 | Alpha 1a adrenoreceptor antagonist | 0.165 0.021 DBMET02409 0.095 0.038 DBMET02410 0.132 0.026 DBMET00437 | ||
| 0.201 | 0.04 | 0.366 | Melanin inhibitor | 0.212 0.037 DBMET02409 0.235 0.031 DBMET02410 0.366 0.014 DBMET02411 0.17 0.06 DBMET02412 0.194 0.043 DBMET00437 0.352 0.016 DBMET00958 | DBMET02411 | |
| 0.225 | 0.071 | 0.411 | Peptidyltransferase inhibitor | 0.234 0.063 DBMET02409 0.3 0.024 DBMET02410 0.389 0.008 DBMET02411 0.191 0.111 DBMET02412 0.293 0.027 DBMET00437 0.411 0.006 DBMET00958 | DBMET00958 | |
| 0.251 | 0.099 | 0.259 | Ca(v)3.3 blocker | 0.259 0.087 DBMET02409 0.212 0.166 DBMET00437 | DBMET02409 | |
| 0.228 | 0.075 | 0.378 | Cyclic AMP phosphodiesterase inhibitor | 0.253 0.062 DBMET02409 0.236 0.071 DBMET02410 0.378 0.02 DBMET02411 0.251 0.063 DBMET00958 | DBMET02411 | |
| 0.173 | 0.021 | 0.222 | Mucolytic | 0.183 0.018 DBMET02409 0.222 0.009 DBMET02410 0.184 0.018 DBMET02411 0.115 0.059 DBMET02412 0.157 0.029 DBMET00437 0.167 0.024 DBMET00958 | DBMET02410 | |
| 0.229 | 0.078 | 0.229 | Neuropeptide Y2 antagonist | 0.193 0.133 DBMET02409 0.19 0.139 DBMET00437 | ||
| 0.179 | 0.029 | 0.179 | Nav1.6 sodium channel blocker | 0.173 0.033 DBMET02409 0.133 0.076 DBMET02410 0.157 0.046 DBMET00437 | ||
| 0.167 | 0.017 | 0.167 | Acetylcholine nicotinic antagonist | 0.158 0.018 DBMET02409 0.152 0.02 DBMET02410 0.165 0.017 DBMET00437 | ||
| 0.159 | 0.011 | 0.159 | Histamine N-methyltransferase inhibitor | 0.131 0.023 DBMET02409 0.121 0.029 DBMET02410 0.078 0.069 DBMET02412 0.122 0.028 DBMET00437 | ||
| 0.215 | 0.07 | 0.335 | Amyloid beta aggregation inhibitor | 0.335 0.038 DBMET02409 0.137 0.118 DBMET02410 0.146 0.111 DBMET02411 0.145 0.112 DBMET00437 | DBMET02409 | |
| 0.146 | 0.005 | 0.146 | NMDA receptor subunit 3A antagonist | 0.088 0.01 DBMET02409 0.077 0.012 DBMET02410 0.043 0.023 DBMET02412 0.13 0.006 DBMET00437 | ||
| 0.153 | 0.014 | 0.153 | Analgesic, opioid | 0.118 0.023 DBMET02409 0.125 0.021 DBMET02410 0.084 0.043 DBMET02412 0.078 0.05 DBMET00437 | ||
| 0.153 | 0.016 | 0.175 | Anabolic | 0.144 0.021 DBMET02409 0.175 0.008 DBMET02410 0.09 0.079 DBMET02411 0.129 0.031 DBMET02412 0.141 0.023 DBMET00437 | DBMET02410 | |
| 0.14 | 0.005 | 0.142 | Estrogen-related receptor beta agonist | 0.126 0.008 DBMET02409 0.142 0.005 DBMET02410 0.093 0.035 DBMET02412 0.11 0.016 DBMET00437 | DBMET02410 | |
| 0.147 | 0.016 | 0.147 | Estrogen receptor beta antagonist | 0.119 0.033 DBMET02409 0.146 0.017 DBMET02410 0.118 0.035 DBMET02412 0.13 0.023 DBMET00437 | ||
| 0.222 | 0.092 | 0.375 | DNA synthesis inhibitor | 0.189 0.14 DBMET02409 0.287 0.048 DBMET02410 0.375 0.025 DBMET02411 0.185 0.146 DBMET02412 0.185 0.146 DBMET00437 0.326 0.036 DBMET00958 | DBMET02411 | |
| 0.266 | 0.141 | 0.284 | GABA C receptor rho-3 antagonist | 0.284 0.127 DBMET00437 | DBMET00437 | |
| 0.17 | 0.047 | 0.17 | Nav1.2 sodium channel blocker | 0.135 0.068 DBMET02409 0.121 0.082 DBMET02410 0.159 0.052 DBMET00437 | ||
| 0.155 | 0.033 | 0.157 | Ca2+-transporting ATPase inhibitor | 0.15 0.042 DBMET02409 0.157 0.028 DBMET02410 0.15 0.043 DBMET02411 0.143 0.063 DBMET02412 0.145 0.056 DBMET00437 0.141 0.071 DBMET00958 | DBMET02410 | |
| 0.155 | 0.033 | 0.454 | Expectorant | 0.174 0.027 DBMET02409 0.23 0.015 DBMET02410 0.454 0.004 DBMET02411 0.092 0.078 DBMET02412 0.144 0.038 DBMET00437 0.426 0.004 DBMET00958 | DBMET02411 | |
| 0.169 | 0.056 | 0.283 | Lipid peroxidase inhibitor | 0.212 0.037 DBMET02409 0.167 0.057 DBMET02410 0.283 0.021 DBMET02411 0.13 0.084 DBMET00437 0.248 0.027 DBMET00958 | DBMET02411 | |
| 0.172 | 0.059 | 0.368 | Diuretic | 0.172 0.059 DBMET02409 0.156 0.073 DBMET02410 0.368 0.015 DBMET02411 0.218 0.038 DBMET00958 | DBMET02411 | |
| 0.176 | 0.065 | 0.243 | Phospholipase C inhibitor | 0.181 0.059 DBMET02409 0.243 0.026 DBMET02410 0.151 0.104 DBMET02411 0.146 0.114 DBMET00437 | DBMET02410 | |
| 0.171 | 0.063 | 0.246 | Interleukin 6 antagonist | 0.172 0.062 DBMET02409 0.19 0.047 DBMET02410 0.246 0.024 DBMET02411 0.136 0.114 DBMET00437 0.212 0.034 DBMET00958 | DBMET02411 | |
| 0.151 | 0.044 | 0.25 | Cholesterol synthesis inhibitor | 0.158 0.041 DBMET02409 0.25 0.018 DBMET02410 0.11 0.075 DBMET02411 | DBMET02410 | |
| 0.119 | 0.014 | 0.159 | Estrogen agonist | 0.077 0.024 DBMET02409 0.159 0.01 DBMET02410 0.062 0.029 DBMET02411 0.069 0.026 DBMET02412 0.092 0.019 DBMET00437 0.05 0.035 DBMET00958 | DBMET02410 | |
| 0.286 | 0.181 | 0.357 | 5 Hydroxytryptamine release inhibitor | 0.352 0.113 DBMET02411 0.291 0.175 DBMET00437 0.357 0.109 DBMET00958 | DBMET00958 | |
| 0.111 | 0.012 | 0.111 | CC chemokine 5 receptor agonist | 0.092 0.033 DBMET02409 0.085 0.049 DBMET02410 0.085 0.048 DBMET02412 0.1 0.022 DBMET00437 | ||
| 0.118 | 0.019 | 0.122 | Estrogen receptor alpha antagonist | 0.111 0.022 DBMET02409 0.122 0.018 DBMET02410 0.071 0.065 DBMET02412 0.082 0.045 DBMET00437 | DBMET02410 | |
| 0.278 | 0.183 | 0.749 | Cyclophilin D inhibitor | 0.315 0.149 DBMET02409 0.407 0.087 DBMET02410 0.749 0.01 DBMET02411 0.709 0.013 DBMET00958 | DBMET02411 | |
| 0.141 | 0.049 | 0.162 | Vanilloid 1 agonist | 0.159 0.03 DBMET02409 0.133 0.061 DBMET02410 0.129 0.068 DBMET02411 0.162 0.028 DBMET00437 0.148 0.04 DBMET00958 | DBMET00437 | |
| 0.136 | 0.047 | 0.148 | Cystathionine beta-synthase inhibitor | 0.148 0.041 DBMET02409 0.109 0.067 DBMET02410 0.107 0.069 DBMET02411 0.093 0.085 DBMET02412 0.108 0.069 DBMET00437 | DBMET02409 | |
| 0.205 | 0.117 | 0.314 | 5 Hydroxytryptamine release stimulant | 0.205 0.117 DBMET02410 0.314 0.066 DBMET00437 0.175 0.146 DBMET00958 | DBMET00437 | |
| 0.135 | 0.047 | 0.244 | Topoisomerase I inhibitor | 0.13 0.05 DBMET02409 0.148 0.042 DBMET02410 0.244 0.018 DBMET02411 0.217 0.022 DBMET02412 0.196 0.027 DBMET00958 | DBMET02411 | |
| 0.125 | 0.04 | 0.134 | Acetylcholine release stimulant | 0.121 0.047 DBMET02409 0.134 0.03 DBMET02411 0.123 0.044 DBMET00437 0.131 0.033 DBMET00958 | DBMET02411 | |
| 0.199 | 0.115 | 0.527 | Antioxidant | 0.28 0.07 DBMET02409 0.249 0.084 DBMET02410 0.527 0.017 DBMET02411 0.186 0.126 DBMET00437 0.507 0.019 DBMET00958 | DBMET02411 | |
| 0.137 | 0.054 | 0.182 | Adenylate cyclase inhibitor | 0.153 0.043 DBMET02409 0.182 0.029 DBMET02410 0.103 0.082 DBMET00437 | DBMET02410 | |
| 0.086 | 0.005 | 0.086 | GABA uptake inhibitor | 0.076 0.005 DBMET02409 0.046 0.019 DBMET02410 0.047 0.018 DBMET02412 0.052 0.014 DBMET00437 | ||
| 0.121 | 0.04 | 0.121 | Creatine kinase inhibitor | 0.106 0.053 DBMET02409 0.098 0.062 DBMET02410 0.097 0.062 DBMET02412 0.103 0.056 DBMET00437 | ||
| 0.096 | 0.016 | 0.146 | Androgen agonist | 0.078 0.025 DBMET02409 0.146 0.008 DBMET02410 0.066 0.034 DBMET02412 0.081 0.024 DBMET00437 | DBMET02410 | |
| 0.106 | 0.027 | 0.126 | Na+ K+ transporting ATPase inhibitor | 0.103 0.029 DBMET02409 0.121 0.016 DBMET02410 0.126 0.013 DBMET02411 0.073 0.057 DBMET02412 0.078 0.052 DBMET00437 0.11 0.023 DBMET00958 | DBMET02411 | |
| 0.1 | 0.021 | 0.1 | 5 Hydroxytryptamine 1 agonist | 0.077 0.026 DBMET02409 0.075 0.026 DBMET00437 | ||
| 0.125 | 0.047 | 0.126 | GABA C receptor antagonist | 0.097 0.082 DBMET02409 0.126 0.047 DBMET00437 | DBMET00437 | |
| 0.129 | 0.051 | 0.158 | Interleukin 8 antagonist | 0.132 0.048 DBMET02409 0.134 0.046 DBMET02410 0.158 0.029 DBMET00437 | DBMET00437 | |
| 0.109 | 0.033 | 0.184 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.106 0.035 DBMET02409 0.108 0.034 DBMET02410 0.184 0.011 DBMET02412 | DBMET02412 | |
| 0.093 | 0.017 | 0.093 | 5 Hydroxytryptamine 1A agonist | 0.082 0.019 DBMET02409 0.044 0.034 DBMET02410 0.042 0.035 DBMET02412 0.093 0.017 DBMET00437 | ||
| 0.114 | 0.039 | 0.123 | Calcium antagonist | 0.123 0.034 DBMET02409 0.081 0.062 DBMET02410 | DBMET02409 | |
| 0.093 | 0.02 | 0.1 | MAP kinase kinase 7 inhibitor | 0.079 0.05 DBMET02409 0.1 0.013 DBMET02410 0.077 0.054 DBMET02412 0.095 0.018 DBMET00437 | DBMET02410 | |
| 0.084 | 0.011 | 0.104 | Estrogen receptor alpha agonist | 0.044 0.019 DBMET02409 0.104 0.008 DBMET02410 0.04 0.02 DBMET02412 0.061 0.015 DBMET00437 | DBMET02410 | |
| 0.127 | 0.054 | 0.127 | 5 Hydroxytryptamine 2 antagonist | 0.118 0.06 DBMET02409 | ||
| 0.211 | 0.139 | 0.263 | Hypoxia-inducible factor 1 alpha inhibitor | 0.228 0.121 DBMET02409 0.246 0.104 DBMET02410 0.238 0.112 DBMET02411 0.263 0.089 DBMET02412 0.2 0.152 DBMET00437 0.226 0.122 DBMET00958 | DBMET02412 | |
| 0.149 | 0.079 | 0.279 | Interferon gamma antagonist | 0.15 0.078 DBMET02409 0.189 0.045 DBMET02410 0.279 0.023 DBMET02411 0.127 0.117 DBMET02412 0.149 0.079 DBMET00437 0.279 0.023 DBMET00958 | DBMET00958 | |
| 0.11 | 0.042 | 0.11 | 5 Hydroxytryptamine 2A antagonist | 0.1 0.047 DBMET02409 | ||
| 0.118 | 0.051 | 0.126 | GABA C receptor agonist | 0.103 0.063 DBMET02409 0.091 0.078 DBMET02412 0.126 0.045 DBMET00437 | DBMET00437 | |
| 0.096 | 0.032 | 0.096 | Acetylcholine M4 receptor antagonist | 0.085 0.041 DBMET02409 0.068 0.06 DBMET02410 0.066 0.062 DBMET00437 | ||
| 0.127 | 0.063 | 0.169 | DNA polymerase I inhibitor | 0.161 0.043 DBMET02409 0.169 0.04 DBMET02410 0.156 0.046 DBMET02411 0.1 0.086 DBMET00437 0.139 0.055 DBMET00958 | DBMET02410 | |
| 0.141 | 0.078 | 0.15 | Sphingosine 1-phosphate receptor 5 antagonist | 0.15 0.061 DBMET02409 0.124 0.114 DBMET00437 | DBMET02409 | |
| 0.182 | 0.123 | 0.206 | Nitric-oxide synthase stimulant | 0.191 0.106 DBMET02409 0.186 0.116 DBMET02410 0.181 0.126 DBMET02411 0.175 0.141 DBMET02412 0.206 0.08 DBMET00437 0.204 0.082 DBMET00958 | DBMET00437 | |
| 0.117 | 0.06 | 0.123 | Alpha 2b adrenoreceptor antagonist | 0.121 0.057 DBMET02409 0.123 0.056 DBMET00437 | DBMET00437 | |
| 0.119 | 0.062 | 0.119 | Transcription factor STAT6 inhibitor | 0.106 0.09 DBMET02409 0.106 0.089 DBMET02410 0.118 0.064 DBMET00437 | ||
| 0.17 | 0.118 | 0.327 | Hypolipemic | 0.166 0.122 DBMET02409 0.303 0.048 DBMET02410 0.327 0.041 DBMET02411 0.264 0.061 DBMET00958 | DBMET02411 | |
| 0.214 | 0.161 | 0.638 | Antithrombotic | 0.226 0.147 DBMET02409 0.248 0.127 DBMET02410 0.638 0.013 DBMET02411 0.21 0.165 DBMET00437 0.635 0.013 DBMET00958 | DBMET02411 | |
| 0.073 | 0.021 | 0.078 | Heme oxygenase stimulant | 0.074 0.021 DBMET02409 0.062 0.04 DBMET02410 0.058 0.052 DBMET02411 0.067 0.029 DBMET02412 0.078 0.017 DBMET00437 0.062 0.041 DBMET00958 | DBMET00437 | |
| 0.1 | 0.049 | 0.1 | Ca(v)2.2 blocker | 0.083 0.062 DBMET02409 0.076 0.069 DBMET00437 | ||
| 0.147 | 0.097 | 0.369 | Nitric oxide antagonist | 0.176 0.078 DBMET02409 0.202 0.066 DBMET02410 0.369 0.029 DBMET02411 0.135 0.111 DBMET02412 0.138 0.108 DBMET00437 0.348 0.032 DBMET00958 | DBMET02411 | |
| 0.136 | 0.086 | 0.149 | Peroxidase inhibitor | 0.149 0.078 DBMET02409 0.136 0.086 DBMET00437 | DBMET02409 | |
| 0.128 | 0.079 | 0.137 | Sphingosine 1-phosphate receptor 2 antagonist | 0.137 0.06 DBMET02409 0.133 0.068 DBMET00437 | DBMET02409 | |
| 0.111 | 0.063 | 0.537 | DNA intercalator | 0.102 0.072 DBMET02409 0.098 0.075 DBMET02410 0.172 0.034 DBMET02411 0.537 0.005 DBMET02412 0.111 0.063 DBMET00958 | DBMET02412 | |
| 0.069 | 0.022 | 0.073 | Beta 2 adrenoreceptor agonist | 0.07 0.019 DBMET02409 0.067 0.026 DBMET02410 0.073 0.015 DBMET00437 | DBMET00437 | |
| 0.153 | 0.106 | 0.432 | Hepatoprotectant | 0.173 0.086 DBMET02409 0.224 0.052 DBMET02410 0.411 0.012 DBMET02411 0.195 0.068 DBMET00437 0.432 0.011 DBMET00958 | DBMET00958 | |
| 0.066 | 0.02 | 0.179 | Alpha-mannosidase inhibitor | 0.059 0.028 DBMET02409 0.086 0.009 DBMET02410 0.168 0.004 DBMET02411 0.055 0.035 DBMET02412 0.068 0.018 DBMET00437 0.179 0.003 DBMET00958 | DBMET00958 | |
| 0.087 | 0.042 | 0.087 | Ca(v)3.1 blocker | 0.083 0.053 DBMET02409 0.076 0.074 DBMET00437 | ||
| 0.068 | 0.024 | 0.077 | Lipocortins synthesis agonist | 0.067 0.025 DBMET02409 0.075 0.017 DBMET02410 0.077 0.016 DBMET02411 0.063 0.031 DBMET02412 0.065 0.028 DBMET00437 0.075 0.017 DBMET00958 | DBMET02411 | |
| 0.057 | 0.013 | 0.058 | Glucocorticoid antagonist | 0.056 0.013 DBMET02409 0.058 0.012 DBMET02410 0.033 0.022 DBMET02412 0.052 0.014 DBMET00437 | DBMET02410 | |
| 0.094 | 0.051 | 0.14 | Androgen antagonist | 0.089 0.056 DBMET02409 0.14 0.025 DBMET02410 0.085 0.059 DBMET00437 | DBMET02410 | |
| 0.082 | 0.04 | 0.176 | Phosphofructokinase-1 inhibitor | 0.07 0.047 DBMET02409 0.097 0.033 DBMET02410 0.176 0.014 DBMET02411 0.066 0.051 DBMET02412 0.069 0.048 DBMET00437 0.158 0.017 DBMET00958 | DBMET02411 | |
| 0.134 | 0.093 | 0.134 | Neuropeptide Y1 antagonist | 0.125 0.111 DBMET00437 | ||
| 0.126 | 0.086 | 0.299 | Protein kinase stimulant | 0.135 0.079 DBMET02409 0.186 0.047 DBMET02410 0.252 0.026 DBMET02411 0.16 0.062 DBMET00437 0.299 0.017 DBMET00958 | DBMET00958 | |
| 0.117 | 0.078 | 0.12 | Nav1.3 sodium channel blocker | 0.1 0.097 DBMET02409 0.12 0.074 DBMET00437 | DBMET00437 | |
| 0.056 | 0.018 | 0.09 | Estrogen receptor beta agonist | 0.09 0.013 DBMET02410 | DBMET02410 | |
| 0.042 | 0.004 | 0.042 | Estrogen-related receptor gamma antagonist | 0.036 0.007 DBMET02409 0.03 0.016 DBMET02410 0.034 0.01 DBMET00437 | ||
| 0.116 | 0.079 | 0.116 | Glutamate receptor antagonist | 0.106 0.089 DBMET00437 | ||
| 0.053 | 0.016 | 0.059 | Dopamine D5 agonist | 0.059 0.012 DBMET02409 0.039 0.029 DBMET02412 0.054 0.015 DBMET00437 | DBMET02409 | |
| 0.116 | 0.08 | 0.213 | DNA repair enzyme inhibitor | 0.116 0.081 DBMET02409 0.121 0.071 DBMET02410 0.213 0.007 DBMET02411 0.154 0.028 DBMET02412 0.109 0.097 DBMET00437 0.202 0.009 DBMET00958 | DBMET02411 | |
| 0.056 | 0.021 | 0.057 | Estradiol 17 beta-dehydrogenase inhibitor | 0.057 0.021 DBMET02409 0.056 0.022 DBMET02410 0.036 0.034 DBMET00437 | DBMET02409 | |
| 0.055 | 0.021 | 0.068 | Adenylate cyclase 1 inhibitor | 0.049 0.028 DBMET02409 0.068 0.013 DBMET02410 | DBMET02410 | |
| 0.057 | 0.024 | 0.063 | Topoisomerase II beta inhibitor | 0.063 0.02 DBMET02409 | DBMET02409 | |
| 0.089 | 0.057 | 0.112 | Opioid antagonist | 0.112 0.04 DBMET00437 | DBMET00437 | |
| 0.108 | 0.078 | 0.158 | Microtubule formation inhibitor | 0.116 0.065 DBMET02409 0.126 0.054 DBMET02410 0.145 0.04 DBMET02411 0.116 0.066 DBMET00437 0.158 0.034 DBMET00958 | DBMET00958 | |
| 0.1 | 0.07 | 0.166 | Toll-Like receptor 4 antagonist | 0.094 0.08 DBMET02409 0.118 0.046 DBMET02410 0.166 0.014 DBMET02411 0.158 0.017 DBMET00958 | DBMET02411 | |
| 0.138 | 0.109 | 0.142 | Antipruritic | 0.137 0.111 DBMET02410 0.142 0.103 DBMET00437 | DBMET00437 | |
| 0.106 | 0.077 | 0.154 | Photosensitizer | 0.1 0.088 DBMET02410 0.154 0.028 DBMET02411 0.109 0.073 DBMET00958 | DBMET02411 | |
| 0.135 | 0.106 | 0.142 | CF transmembrane conductance regulator agonist | 0.142 0.092 DBMET02410 | DBMET02410 | |
| 0.066 | 0.037 | 0.069 | Calcium channel P-type blocker | 0.069 0.03 DBMET02409 0.067 0.035 DBMET02410 | DBMET02409 | |
| 0.039 | 0.012 | 0.039 | Estrogen-related receptor beta antagonist | 0.036 0.015 DBMET02410 | ||
| 0.068 | 0.042 | 0.069 | Dopamine D1 antagonist | 0.069 0.041 DBMET02409 | DBMET02409 | |
| 0.105 | 0.081 | 0.22 | Topoisomerase II inhibitor | 0.102 0.084 DBMET02409 0.11 0.077 DBMET02410 0.22 0.029 DBMET02411 0.188 0.036 DBMET02412 0.166 0.043 DBMET00958 | DBMET02411 | |
| 0.05 | 0.026 | 0.169 | Mannosidase inhibitor | 0.043 0.035 DBMET02409 0.07 0.012 DBMET02410 0.158 0.004 DBMET02411 0.052 0.023 DBMET00437 0.169 0.004 DBMET00958 | DBMET00958 | |
| 0.065 | 0.041 | 0.066 | Acetylcholine M2 receptor antagonist | 0.066 0.04 DBMET00437 | DBMET00437 | |
| 0.078 | 0.054 | 0.153 | Topoisomerase II alpha inhibitor | 0.073 0.059 DBMET02409 0.076 0.056 DBMET02410 0.153 0.023 DBMET02411 0.112 0.033 DBMET00958 | DBMET02411 | |
| 0.08 | 0.057 | 0.09 | Opioid kappa receptor antagonist | 0.09 0.045 DBMET00437 | DBMET00437 | |
| 0.041 | 0.019 | 0.055 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.04 0.02 DBMET02409 0.055 0.009 DBMET02410 0.05 0.012 DBMET02412 | DBMET02410 | |
| 0.092 | 0.071 | 0.096 | Carbonic anhydrase III inhibitor | 0.096 0.067 DBMET02409 | DBMET02409 | |
| 0.052 | 0.031 | 0.062 | Squalene epoxidase inhibitor | 0.062 0.019 DBMET02409 0.051 0.032 DBMET02410 | DBMET02409 | |
| 0.164 | 0.143 | 0.462 | Immunostimulant | 0.155 0.151 DBMET02409 0.253 0.095 DBMET02410 0.462 0.035 DBMET02411 0.438 0.039 DBMET00958 | DBMET02411 | |
| 0.044 | 0.024 | 0.049 | Liver X receptor alpha agonist | 0.047 0.021 DBMET02409 0.049 0.02 DBMET02410 | DBMET02410 | |
| 0.104 | 0.084 | 0.212 | Alkylator | 0.097 0.092 DBMET02409 0.142 0.051 DBMET02410 0.212 0.023 DBMET02411 0.181 0.033 DBMET02412 0.097 0.092 DBMET00437 0.203 0.025 DBMET00958 | DBMET02411 | |
| 0.059 | 0.04 | 0.059 | Ryanodine receptor antagonist | 0.058 0.042 DBMET02409 0.056 0.051 DBMET02410 0.056 0.05 DBMET00437 | ||
| 0.038 | 0.019 | 0.038 | Glutamate (mGluR8) antagonist | 0.038 0.021 DBMET02409 0.034 0.029 DBMET02410 0.036 0.025 DBMET02411 0.034 0.03 DBMET02412 0.037 0.023 DBMET00437 0.035 0.027 DBMET00958 | ||
| 0.057 | 0.039 | 0.06 | Fatty acid synthase inhibitor | 0.06 0.035 DBMET02409 | DBMET02409 | |
| 0.132 | 0.113 | 0.135 | Heat shock protein 70 antagonist | 0.133 0.107 DBMET02409 0.135 0.095 DBMET02411 | DBMET02411 | |
| 0.033 | 0.015 | 0.034 | Liver X receptor alpha antagonist | 0.034 0.013 DBMET02409 | DBMET02409 | |
| 0.077 | 0.061 | 0.12 | Adrenaline agonist | 0.078 0.06 DBMET02409 0.12 0.025 DBMET00437 | DBMET00437 | |
| 0.093 | 0.078 | 0.093 | Falcipain 3 inhibitor | 0.092 0.079 DBMET02409 | ||
| 0.044 | 0.029 | 0.05 | Dopamine D5 antagonist | 0.05 0.025 DBMET02409 | DBMET02409 | |
| 0.221 | 0.206 | 0.628 | Antibacterial | 0.234 0.192 DBMET02409 0.314 0.125 DBMET02410 0.614 0.017 DBMET02411 0.252 0.175 DBMET00437 0.628 0.015 DBMET00958 | DBMET00958 | |
| 0.097 | 0.083 | 0.105 | DOPA decarboxylase inhibitor | 0.105 0.067 DBMET02409 0.093 0.09 DBMET02412 | DBMET02409 | |
| 0.033 | 0.021 | 0.033 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.032 0.022 DBMET02410 | ||
| 0.071 | 0.059 | 0.071 | GABA aminotransferase inhibitor | |||
| 0.021 | 0.009 | 0.021 | Estrogen-related receptor gamma agonist | 0.02 0.01 DBMET02409 0.02 0.01 DBMET00437 | ||
| 0.017 | 0.006 | 0.018 | Antibiotic Tetracycline-like | 0.017 0.007 DBMET02409 0.018 0.005 DBMET02410 | DBMET02410 | |
| 0.031 | 0.021 | 0.033 | Liver X receptor antagonist | 0.033 0.02 DBMET02409 | DBMET02409 | |
| 0.028 | 0.017 | 0.038 | Hedgehog signaling activator | 0.027 0.019 DBMET02409 0.038 0.005 DBMET02410 | DBMET02410 | |
| 0.187 | 0.177 | 0.207 | Insulysin inhibitor | 0.207 0.146 DBMET00437 | DBMET00437 | |
| 0.036 | 0.026 | 0.048 | Glutamate (mGluR3) antagonist | 0.048 0.013 DBMET02410 | DBMET02410 | |
| 0.027 | 0.019 | 0.027 | Urotensin II agonist | |||
| 0.063 | 0.057 | 0.063 | Glutamate (mGluR7) antagonist | |||
| 0.055 | 0.051 | 0.055 | Acetylcholine M5 receptor antagonist | |||
| 0.038 | 0.034 | 0.041 | Oxytocin agonist | 0.041 0.031 DBMET00437 | DBMET00437 | |
| 0.076 | 0.073 | 0.085 | Histamine H2 receptor antagonist | 0.081 0.063 DBMET02409 0.085 0.054 DBMET00437 | DBMET00437 | |
| 0.059 | 0.055 | 0.079 | Opioid mu receptor antagonist | 0.079 0.04 DBMET00437 | DBMET00437 | |
| 0.092 | 0.089 | 0.092 | Nav1.4 sodium channel blocker | |||
| 0.024 | 0.022 | 0.038 | Vanilloid 2 agonist | 0.025 0.018 DBMET02409 0.038 0.005 DBMET02411 0.037 0.005 DBMET00958 | DBMET02411 | |
| 0.059 | 0.058 | 0.065 | Beta 3 adrenoreceptor antagonist | 0.06 0.054 DBMET02409 0.065 0.042 DBMET00437 | DBMET00437 | |
| 0.059 | 0.058 | 0.064 | Beta adrenoreceptor antagonist | 0.064 0.049 DBMET02409 0.06 0.055 DBMET00437 | DBMET02409 | |
| 0.025 | 0.024 | 0.025 | Liver X receptor beta antagonist | |||
| 0.047 | 0.046 | 0.051 | Acyl-CoA dehydrogenase inhibitor | 0.051 0.041 DBMET02410 | DBMET02410 | |
| 0.112 | 0.112 | 0.284 | Cell wall synthesis inhibitor | 0.268 0.013 DBMET02411 0.125 0.092 DBMET00437 0.284 0.011 DBMET00958 | DBMET00958 | |
| 0.065 | 0.065 | 0.075 | Glutamate dehydrogenase inhibitor | 0.067 0.06 DBMET02410 0.075 0.05 DBMET00437 | DBMET00437 | |
| 0.01 | 0.011 | 0.014 | Glucocorticoid agonist | 0.014 0.009 DBMET02410 | DBMET02410 | |
| 0.147 | 0.148 | 0.451 | Free radical scavenger | 0.241 0.072 DBMET02409 0.17 0.124 DBMET02410 0.451 0.022 DBMET02411 0.437 0.023 DBMET00958 | DBMET02411 | |
| 0.048 | 0.049 | 0.065 | Leukotriene B4 antagonist | 0.051 0.042 DBMET02409 0.065 0.023 DBMET02411 0.053 0.039 DBMET00958 | DBMET02411 | |
| 0.015 | 0.016 | 0.018 | Vitamin D receptor agonist | 0.018 0.008 DBMET02410 | DBMET02410 | |
| 0.023 | 0.026 | 0.059 | RNA-directed RNA polymerase stimulant | 0.059 0.011 DBMET02410 | DBMET02410 | |
| 0.013 | 0.016 | 0.015 | Thyroid hormone alpha antagonist | 0.015 0.012 DBMET02409 | DBMET02409 | |
| 0.06 | 0.063 | 0.064 | Dopamine antagonist | 0.064 0.059 DBMET02409 | DBMET02409 | |
| 0.017 | 0.021 | 0.027 | Antibiotic Anthracycline-like | 0.02 0.011 DBMET02410 0.027 0.004 DBMET02411 0.025 0.005 DBMET00958 | DBMET02411 | |
| 0.151 | 0.155 | 0.314 | Vasodilator | 0.185 0.117 DBMET02409 0.193 0.11 DBMET02410 0.314 0.044 DBMET02411 0.295 0.05 DBMET00958 | DBMET02411 | |
| 0.041 | 0.046 | 0.044 | Cholesterol esterase inhibitor | 0.044 0.041 DBMET02410 | DBMET02410 | |
| 0.098 | 0.104 | 0.206 | Alpha-N-acetylglucosaminidase inhibitor | 0.117 0.081 DBMET02410 0.185 0.039 DBMET02411 0.11 0.089 DBMET00437 0.206 0.032 DBMET00958 | DBMET00958 | |
| 0.042 | 0.048 | 0.047 | Beta adrenoreceptor agonist | 0.047 0.026 DBMET00437 | DBMET00437 | |
| 0.061 | 0.068 | 0.069 | Glutamate decarboxylase inhibitor | 0.069 0.056 DBMET02409 | DBMET02409 | |
| 0.039 | 0.045 | 0.046 | Histamine H1 receptor agonist | 0.046 0.024 DBMET00437 | DBMET00437 | |
| 0.016 | 0.025 | 0.021 | Corticosteroid-like | 0.02 0.017 DBMET02410 0.021 0.014 DBMET02411 0.021 0.016 DBMET00958 | DBMET00958 | |
| 0.055 | 0.066 | 0.093 | Phenylalanine 4-hydroxylase inhibitor | 0.07 0.046 DBMET02409 0.093 0.029 DBMET00437 | DBMET00437 | |
| 0.056 | 0.067 | 0.116 | NMDA 2 receptor antagonist | 0.116 0.025 DBMET00437 | DBMET00437 | |
| 0.018 | 0.03 | 0.061 | Protein 30S ribosomal subunit inhibitor | 0.021 0.02 DBMET02410 0.061 0.006 DBMET02411 0.057 0.007 DBMET00958 | DBMET02411 | |
| 0.088 | 0.101 | 0.096 | Protein kinase C gamma inhibitor | 0.096 0.083 DBMET02410 | DBMET02410 | |
| 0.036 | 0.049 | 0.048 | Potassium channel Kv1.3 blocker | 0.048 0.031 DBMET02410 | DBMET02410 | |
| 0.101 | 0.114 | 0.114 | Calcium channel blocker | 0.114 0.095 DBMET00437 | DBMET00437 | |
| 0.067 | 0.081 | 0.072 | GABA B receptor agonist | 0.071 0.064 DBMET02409 0.072 0.061 DBMET00437 | DBMET00437 | |
| 0.159 | 0.173 | 0.184 | Superoxide dismutase inhibitor | 0.184 0.136 DBMET02409 | DBMET02409 | |
| 0.079 | 0.094 | 0.085 | Glutamate release inhibitor | 0.085 0.076 DBMET02411 0.085 0.075 DBMET00958 | DBMET00958 | |
| 0.027 | 0.042 | 0.031 | Glutamate (mGluR3) agonist | 0.031 0.025 DBMET00437 | DBMET00437 | |
| 0.107 | 0.121 | 0.138 | Neurotrophic factor | 0.126 0.086 DBMET02409 0.138 0.071 DBMET02410 | DBMET02410 | |
| 0.069 | 0.087 | 0.078 | Myeloperoxidase inhibitor | 0.078 0.07 DBMET00437 | DBMET00437 | |
| 0.034 | 0.053 | 0.098 | NMDA 2A receptor antagonist | 0.098 0.014 DBMET00437 | DBMET00437 | |
| 0.141 | 0.16 | 0.23 | Antiamyloidogenic | 0.18 0.114 DBMET02409 0.205 0.096 DBMET02411 0.157 0.137 DBMET00437 0.23 0.081 DBMET00958 | DBMET00958 | |
| 0.084 | 0.103 | 0.111 | Chelator | 0.111 0.063 DBMET02409 | DBMET02409 | |
| 0.066 | 0.085 | 0.113 | Glycine receptor antagonist | 0.085 0.049 DBMET02410 0.113 0.022 DBMET02411 0.101 0.031 DBMET00958 | DBMET02411 | |
| 0.04 | 0.061 | 0.088 | Alcohol oxidase inhibitor | 0.088 0.021 DBMET02410 | DBMET02410 | |
| 0.039 | 0.061 | 0.05 | Aromatase inhibitor | 0.05 0.048 DBMET02410 | DBMET02410 | |
| 0.076 | 0.098 | 0.166 | UDP-glucose 4-epimerase inhibitor | 0.166 0.024 DBMET02411 0.148 0.029 DBMET00958 | DBMET02411 | |
| 0.027 | 0.05 | 0.075 | Antibiotic Aminoglycoside-like | 0.036 0.026 DBMET02410 0.075 0.005 DBMET02411 0.075 0.005 DBMET00958 | DBMET00958 | |
| 0.076 | 0.099 | 0.124 | Lanosterol 14 alpha demethylase inhibitor | 0.124 0.027 DBMET02410 | DBMET02410 | |
| 0.031 | 0.056 | 0.046 | Histamine H2 receptor agonist | 0.046 0.026 DBMET00437 | DBMET00437 | |
| 0.13 | 0.159 | 0.144 | Neurotensin receptor agonist | 0.144 0.117 DBMET00437 | DBMET00437 | |
| 0.035 | 0.065 | 0.107 | Protein 50S ribosomal subunit inhibitor | 0.056 0.034 DBMET02410 0.107 0.012 DBMET02411 0.1 0.013 DBMET00958 | DBMET02411 | |
| 0.104 | 0.135 | 0.13 | Papain-like protease (SARS coronavirus) inhibitor | 0.13 0.06 DBMET00437 | DBMET00437 | |
| 0.069 | 0.103 | 0.116 | NADH dehydrogenase inhibitor | 0.116 0.031 DBMET02411 0.1 0.044 DBMET00958 | DBMET02411 | |
| 0.078 | 0.115 | 0.115 | Phosphodiesterase 6D inhibitor | 0.115 0.03 DBMET02411 0.087 0.085 DBMET00958 | DBMET02411 | |
| 0.127 | 0.164 | 0.14 | Succinate dehydrogenase inhibitor | 0.14 0.131 DBMET02409 | DBMET02409 | |
| 0.048 | 0.086 | 0.186 | Antineoplastic antibiotic | 0.093 0.05 DBMET02410 0.186 0.024 DBMET02411 0.172 0.026 DBMET00958 | DBMET02411 | |
| 0.003 | 0.042 | 0.013 | Antibiotic Macrolide-like | 0.013 0.011 DBMET02411 | DBMET02411 | |
| 0.045 | 0.085 | 0.067 | Neuronal nicotinic receptor antagonist | 0.067 0.047 DBMET00437 | DBMET00437 | |
| 0.049 | 0.09 | 0.059 | Bcl-xL inhibitor | 0.059 0.044 DBMET02409 | DBMET02409 | |
| 0.143 | 0.185 | 0.293 | DNA damaging | 0.176 0.139 DBMET02410 0.16 0.158 DBMET02411 0.293 0.06 DBMET02412 0.181 0.133 DBMET00437 0.205 0.111 DBMET00958 | DBMET02412 | |
| 0.029 | 0.074 | 0.036 | Vanilloid 3 antagonist | 0.036 0.033 DBMET02410 | DBMET02410 | |
| 0.034 | 0.079 | 0.05 | Glucose-6-phosphate isomerase inhibitor | 0.05 0.029 DBMET02411 0.045 0.039 DBMET00958 | DBMET02411 | |
| 0.071 | 0.117 | 0.109 | Protein-tyrosine phosphatase 1B inhibitor | 0.109 0.07 DBMET02411 | DBMET02411 | |
| 0.103 | 0.149 | 0.147 | Farnesoid X receptor antagonist | 0.147 0.056 DBMET02410 | DBMET02410 | |
| 0.054 | 0.102 | 0.075 | Glycine receptor agonist | 0.075 0.046 DBMET02410 | DBMET02410 | |
| 0.082 | 0.135 | 0.102 | Electron transport complex I inhibitor | 0.102 0.077 DBMET02409 | DBMET02409 | |
| 0.012 | 0.065 | 0.043 | Arginase inhibitor | 0.041 0.021 DBMET02411 0.043 0.02 DBMET00958 | DBMET00958 | |
| 0.07 | 0.124 | 0.095 | T cell inhibitor | 0.078 0.073 DBMET02410 0.095 0.029 DBMET02411 0.087 0.045 DBMET00958 | DBMET02411 | |
| 0.024 | 0.078 | 0.041 | Guanylate cyclase inhibitor | 0.041 0.032 DBMET02412 | DBMET02412 | |
| 0.029 | 0.084 | 0.046 | Beta 2 adrenoreceptor antagonist | 0.046 0.043 DBMET00437 | DBMET00437 | |
| 0.064 | 0.119 | 0.118 | Triose-phosphate isomerase inhibitor | 0.118 0.033 DBMET02411 0.105 0.043 DBMET00958 | DBMET02411 | |
| 0.035 | 0.093 | 0.083 | Glucose-6-phosphate translocase inhibitor | 0.047 0.045 DBMET02409 0.083 0.01 DBMET02411 0.074 0.014 DBMET00958 | DBMET02411 | |
| 0.051 | 0.11 | 0.086 | Ornithine decarboxylase inhibitor | 0.086 0.061 DBMET00437 | DBMET00437 | |
| 0.009 | 0.069 | 0.039 | Squalene synthetase inhibitor | 0.039 0.018 DBMET02411 0.03 0.023 DBMET00958 | DBMET02411 | |
| 0.054 | 0.114 | 0.075 | Interferon agonist | 0.075 0.06 DBMET02411 | DBMET02411 | |
| 0.111 | 0.174 | 0.143 | CC chemokine 6 receptor antagonist | 0.143 0.033 DBMET02411 0.137 0.048 DBMET00958 | DBMET02411 | |
| 0.169 | 0.232 | 0.412 | Apoptosis antagonist | 0.206 0.171 DBMET02409 0.255 0.123 DBMET02410 0.389 0.042 DBMET02411 0.226 0.15 DBMET00437 0.412 0.035 DBMET00958 | DBMET00958 | |
| 0.114 | 0.179 | 0.157 | Anticonvulsant | 0.157 0.121 DBMET00437 | DBMET00437 | |
| 0.103 | 0.168 | 0.141 | GABA C receptor rho-2 antagonist | 0.141 0.087 DBMET00437 | DBMET00437 | |
| 0.067 | 0.137 | 0.094 | GABA C receptor rho-1 antagonist | 0.094 0.071 DBMET00437 | DBMET00437 | |
| 0.057 | 0.129 | 0.15 | Mediator release inhibitor | 0.15 0.029 DBMET02411 0.131 0.039 DBMET00958 | DBMET02411 | |
| 0.095 | 0.168 | 0.204 | Hexokinase inhibitor | 0.204 0.033 DBMET02411 0.177 0.051 DBMET00958 | DBMET02411 | |
| 0.015 | 0.09 | 0.035 | Catechol O-methyltransferase inhibitor | 0.035 0.02 DBMET02409 | DBMET02409 | |
| 0.111 | 0.187 | 0.278 | Non-steroidal antiinflammatory agent | 0.267 0.036 DBMET02411 0.278 0.033 DBMET00958 | DBMET00958 | |
| 0.012 | 0.091 | 0.038 | Complement C3a chemotactic receptor antagonist | 0.038 0.034 DBMET00437 | DBMET00437 | |
| 0.025 | 0.108 | 0.043 | Glucose-6-phosphate dehydrogenase inhibitor | 0.043 0.017 DBMET02410 | DBMET02410 | |
| 0.01 | 0.094 | 0.054 | Sodium/glucose cotransporter 2 inhibitor | 0.054 0.005 DBMET02411 0.04 0.008 DBMET00958 | DBMET02411 | |
| 0.074 | 0.161 | 0.219 | Cyclooxygenase 3 inhibitor | 0.219 0.013 DBMET02411 0.217 0.014 DBMET00958 | DBMET02411 | |
| 0.063 | 0.152 | 0.085 | Vanilloid agonist | 0.085 0.058 DBMET02409 | DBMET02409 | |
| 0.046 | 0.138 | 0.146 | Monophenol monooxygenase inhibitor | 0.139 0.051 DBMET02411 0.146 0.049 DBMET00958 | DBMET00958 | |
| 0.012 | 0.107 | 0.05 | Sodium/glucose cotransporter inhibitor | 0.045 0.006 DBMET02411 0.05 0.005 DBMET00958 | DBMET00958 | |
| 0.032 | 0.145 | 0.05 | Vanilloid 2 antagonist | 0.05 0.041 DBMET02409 | DBMET02409 | |
| 0.023 | 0.135 | 0.045 | Microtubule stabilization | 0.043 0.037 DBMET02411 0.045 0.035 DBMET00958 | DBMET00958 | |
| 0.009 | 0.128 | 0.023 | Motilin receptor agonist | 0.023 0.015 DBMET02411 0.022 0.017 DBMET00958 | DBMET02411 | |
| 0.057 | 0.188 | 0.133 | Beta glucuronidase inhibitor | 0.133 0.035 DBMET02411 0.126 0.04 DBMET00958 | DBMET02411 | |
| 0.031 | 0.169 | 0.047 | Factor III inhibitor | 0.047 0.043 DBMET00958 | DBMET00958 | |
| 0.052 | 0.207 | 0.217 | Amylase inhibitor | 0.217 0.039 DBMET02411 0.199 0.045 DBMET00958 | DBMET02411 | |
| 0.042 | 0.202 | 0.101 | Bronchodilator | 0.101 0.063 DBMET02410 | DBMET02410 | |
| 0.078 | 0.253 | 0.26 | Interleukin agonist | 0.174 0.145 DBMET02410 0.238 0.088 DBMET02411 0.26 0.072 DBMET00958 | DBMET00958 | |
| 0.133 | 0.328 | 0.213 | Caspase 3 stimulant | 0.213 0.151 DBMET02411 0.205 0.162 DBMET00958 | DBMET02411 | |
| 0.047 | 0.247 | 0.27 | Thrombolytic | 0.27 0.029 DBMET02411 0.241 0.036 DBMET00958 | DBMET02411 | |
| 0.136 | 0.337 | 0.376 | Interleukin 2 agonist | 0.285 0.085 DBMET02410 0.376 0.035 DBMET02411 0.376 0.035 DBMET00958 | DBMET00958 | |
| 0.07 | 0.28 | 0.207 | NOS3 expression enhancer | 0.207 0.038 DBMET02411 0.187 0.046 DBMET00958 | DBMET02411 | |
| 0.005 | 0.226 | 0.121 | Kinesin-like protein 1 inhibitor | 0.121 0.005 DBMET02412 | DBMET02412 | |
| 0.005 | 0.226 | 0.121 | Kinesin antagonist | 0.121 0.005 DBMET02412 | DBMET02412 | |
| 0.031 | 0.253 | 0.054 | Adenine nucleotide translocase inhibitor | 0.054 0.043 DBMET02411 0.054 0.044 DBMET00958 | DBMET00958 | |
| 0.112 | 0.342 | 0.246 | Antiobesity | 0.246 0.16 DBMET02411 | DBMET02411 | |
| 0.016 | 0.246 | 0.329 | Selectin antagonist | 0.326 0.005 DBMET02411 0.329 0.004 DBMET00958 | DBMET00958 | |
| 0.038 | 0.28 | 0.146 | AMP-activated protein kinase stimulant | 0.146 0.031 DBMET02411 0.143 0.033 DBMET00958 | DBMET02411 | |
| 0.009 | 0.254 | 0.048 | Purinergic P2X7 antagonist | 0.048 0.015 DBMET00437 | DBMET00437 | |
| 0.049 | 0.295 | 0.579 | Angiogenesis stimulant | 0.579 0.008 DBMET02411 0.567 0.008 DBMET00958 | DBMET02411 | |
| 0.006 | 0.254 | 0.025 | Factor IX inhibitor | 0.025 0.008 DBMET00437 | DBMET00437 | |
| 0.014 | 0.267 | 0.044 | Neuraminidase (Influenza A) inhibitor | 0.043 0.036 DBMET02411 0.044 0.035 DBMET00958 | DBMET00958 | |
| 0.13 | 0.399 | 0.485 | Apoptosis agonist | 0.262 0.202 DBMET02410 0.453 0.09 DBMET02411 0.485 0.079 DBMET00958 | DBMET00958 | |
| 0.021 | 0.292 | 0.129 | Factor IXa inhibitor | 0.076 0.018 DBMET02411 0.101 0.01 DBMET00437 0.129 0.005 DBMET00958 | DBMET00958 | |
| 0.043 | 0.318 | 0.129 | Transcription factor NF kappa B stimulant | 0.119 0.026 DBMET02411 0.129 0.022 DBMET00958 | DBMET00958 | |
| 0.079 | 0.356 | 0.55 | Hypoglycemic | 0.55 0.011 DBMET02411 0.521 0.014 DBMET00958 | DBMET02411 | |
| 0.016 | 0.36 | 0.11 | Protein kinase A inhibitor | 0.11 0.039 DBMET00437 | DBMET00437 | |
| 0.012 | 0.381 | 0.059 | Neuraminidase (influenza) inhibitor | 0.059 0.055 DBMET00958 | DBMET00958 | |
| 0.012 | 0.382 | 0.029 | Toll-Like receptor 4 agonist | 0.029 0.013 DBMET02411 0.029 0.014 DBMET00958 | DBMET00958 | |
| 0.017 | 0.389 | 0.064 | Heparanase inhibitor | 0.064 0.018 DBMET02411 0.064 0.017 DBMET00958 | DBMET00958 | |
| 0.038 | 0.442 | 0.139 | Toll-Like receptor 3 antagonist | 0.139 0.018 DBMET00437 | DBMET00437 | |
| 0.043 | 0.453 | 0.197 | Insulin secretagoues | 0.194 0.039 DBMET02411 0.197 0.037 DBMET00958 | DBMET00958 | |
| 0.009 | 0.423 | 0.053 | Purinergic P2X antagonist | 0.053 0.029 DBMET00437 | DBMET00437 | |
| 0.037 | 0.482 | 0.318 | Platelet adhesion inhibitor | 0.318 0.028 DBMET02411 0.298 0.035 DBMET00958 | DBMET02411 | |
| 0.018 | 0.473 | 0.106 | ATPase (Vacuolar H+) inhibitor | 0.103 0.035 DBMET02411 0.106 0.032 DBMET00958 | DBMET00958 | |
| 0.091 | 0.554 | 0.652 | Antiinflammatory | 0.652 0.04 DBMET02411 0.628 0.046 DBMET00958 | DBMET02411 | |
| 0.023 | 0.499 | 0.082 | Thioredoxin inhibitor | 0.082 0.077 DBMET00958 | DBMET00958 | |
| 0.03 | 0.532 | 0.202 | Hemostatic | 0.158 0.059 DBMET02411 0.202 0.032 DBMET00958 | DBMET00958 | |
| 0.03 | 0.559 | 0.304 | Tumour necrosis factor alpha release inhibitor | 0.3 0.053 DBMET02411 0.304 0.052 DBMET00958 | DBMET00958 | |
| 0.018 | 0.561 | 0.211 | Anticoagulant | 0.173 0.064 DBMET02411 0.211 0.049 DBMET00958 | DBMET00958 | |
| 0.04 | 0.642 | 0.314 | Immunomodulator | 0.314 0.075 DBMET02411 0.271 0.099 DBMET00958 | DBMET02411 | |
| 0.016 | 0.622 | 0.197 | Platelet antagonist | 0.197 0.103 DBMET02411 0.177 0.12 DBMET00958 | DBMET02411 | |
| 0.012 | 0.74 | 0.153 | Cell adhesion inhibitor | 0.153 0.045 DBMET02411 0.15 0.047 DBMET00958 | DBMET02411 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |